DETAILED NOTES ON LINSITINIB SIDE EFFECTS

The LIDS demo met its Principal endpoint with statistical importance for your 150mg BID dose. Linsitinib in this demo validated the safety profile found while in the prior oncology reports and importantly demonstrated a good basic safety profile on vital adverse occasions (AEs) of curiosity to the IGF-1R focus on which include Listening to impairme